Physician profile
Charles Su
NPI 1427412097
$46,624.75
in general payments reported to CMS, 2019-2025
7 companies · $5,211 in 2025
The $5,211 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,453 · 2022: $31K · 2023: $629 · 2024: $514 · 2025: $5,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,863 · Food and Beverage: $1,992 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,862.65 |
| Food and Beverage | $1,992.04 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $24,009.05 | 2022 | |
| Smith+Nephew, INC. | $12,937.50 | 2021-2022 | |
| Stryker Corporation | $3,220.74 | 2022-2025 | Iconix, Salvation, Alphavent |
| Synthes Gmbh | $3,211.58 | 2025 | |
| Medical Device Business Services, INC. | $2,984.12 | 2021 | |
| Bodycad USA Corp | $173.35 | 2025 | Fine Osteotomy |
| Fortis Surgical, LLC | $88.41 | 2022-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.